Vebreltinib Combined With Temozolomide for Glioblastoma (GBM) After Surgery

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Vebreltinib Combined With Temozolomide for Glioblastoma (GBM) After Surgery	Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, astrocytoma (excluding glioblastoma), epithelial neoplasm, glioblastoma, glioma, neoplasm, neuroepithelial neoplasm, primitive neuroectodermal tumor	Not yet recruiting	Phase 2	2025-01-22		NCT06780592

3 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Beijing Sanbo Brain Hospital	16
Beijing Tiantan Hospital	307
Huashan Hospital	165

0 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
No products are listed yet.

Clinical trials